You are on page 1of 9

See discussions, stats, and author profiles for this publication at: https://www.researchgate.

net/publication/319514117

Critical Appraisal of Clinical Research

Article in Journal of Clinical and Diagnostic Research · May 2017


DOI: 10.7860/JCDR/2017/26047.9942

CITATIONS
READS
7
1,440

1 author:

Azzam Al-Jundi
King Saud bin Abdulaziz University for Health Sciences
27 PUBLICATIONS 119 CITATIONS

Some of the authors of this publication are also working on these related projects:

Dental Research - Principles and Methodology View project

All content following this page was uploaded by Azzam Al-Jundi on 06 September 2017.

The user has requested enhancement of the downloaded file.


DOI: 10.7860/JCDR/2017/26047.9942
Review Article

Critical Appraisal
Education Section

of Clinical
Research

AzzAm Al-JundI1, SAlAh SAkkA2

AbsTRACT
Evidence-based practice is the integration of individual clinical expertise with the best available external clinical evidence from
systematic research and patient’s values and expectations into the decision making process for patient care. It is a fundamental
skill to be able to identify and appraise the best available evidence in order to integrate it with your own clinical experience and
patients values. The aim of this article is to provide a robust and simple process for assessing the credibility of articles and their
value to your clinical practice.

Keywords: Evidence-based practice, Method assessment, Research design

INTRODUCTION 1. What is the


Decisions related to research question?
patient value and care 2. What is the study
is carefully made type (design)?
following an essential 3. Selection issues.
process of integration of 4. What are the
the best existing outcome factors
evidence, clinical and how are they
experience and patient measured?
preference. Critical 5. What are the study
appraisal is the course factors and how are
of action for watchfully they measured?
and systematically 6. What important
examining research to potential
assess its reliability, confounders are
value and relevance in considered?
order to direct 7. What is the
professionals in their statistical method
vital clinical decision used in the study?
making [1].
8. Statistical results.
Critical appraisal is
9. What conclusions
essential to:
did the authors
• Combat information reach about the
overload;
research question?
• identify papers that are
10. Are ethical issues
clinically relevant;
considered??
• Continuing Professional
Development (CPD). The Critical Appraisal
starts by double
Carrying out Critical checking the following
Appraisal:
main sections:
Assessing the research
I. Overview of the
methods used in the paper:
study is a prime step in
a. The publishing
its critical appraisal.
journal and the year
This is done using
checklists which are b. The article title:
specific to the study Does it state key
trial objectives?
design.
c. The author (s) and
Standard Common
their institution (s)
Questions:

Journal of Clinical and Diagnostic Research. 2017 May, Vol-11(5): JE01- 1


1
JE05
The be well and clearly population, the
include written.
presen sample size and the
author
ce of a b. Materials and interventions
s’
peer Methods: The presented. All
declar
review study design and measurements
ations approaches should
process type of groups,
of be clearly stated
in type of
interes [3].
journal randomization
t and
accepta process, sample V. Results section:
potenti
nce size, gender, age, This section
al
protoco and procedure should clearly
market
ls also rendered to each reveal what
bias.
adds group and actually occur to
Attenti
robustn measuring tool(s) the subjects. The
on
ess to should be results might
should
the evidently contain raw data
be
assess paid to mentioned. and explain the
ment any c. Results: The statistical analysis.
criteria declar measured These can be
for ed variables with shown in related
researc fundin their statistical tables, diagrams
h g or analysis and and graphs.
papers the significance VI. discussion section:
and issue This section
d. Conclusion: It must clearly
hence of a answer the question of should include an
would resear interest. absolute
indicate ch comparison of
III. Introduction/ Background
a grant, what is already
section:
reduce in identified in the
d An excellent
order topic of interest
likeliho introduction will
to and the clinical
od of thoroughly include
check relevance of what
publicat references to earlier
for a has been newly
ion of work related to the
conflict established. A
poor area under discussion
of discussion on a
quality and express the
interes possible related
researc importance and
t [2]. limitations and
h. limitations of what is
II. AB necessitation for
previously
Other further studies
STRA acknowledged [2].
areas should also be
CT:
to -Why this study is indicated.
Readi
conside considered necessary?
ng the
r may What is the purpose of
abstra
this study? Was the
ct is a
purpose identified
quick
before the study or a
way of
chance result revealed
getting
as part of ‘data
to
searching?’
know
the -What has been
article already achieved and
and its how does this study be
purpo at variance?
se, -Does the scientific
major approach outline the
proce advantages along
dures with possible
and drawbacks associated
metho with the intervention or
ds, observations?
main IV. methods and
finding materials section:
s, and Full details on
conclu how the study was
sions. actually carried out
a. Aim of should be mentioned.
the Precise information
study: It is given on the
should study design, the
2
2 Journal of Clinical and Diagnostic Research. 2017 May, Vol-11(5): JE01-
JE05
Azzam Al-Jundi and Salah Sakka, Critical Appraisal of Clinical Research www.jcdr.net

Clinical Relevance and Suggested 2- What is the study type (design)?


Clinical Questions
Best method of Investigation
The study design of the research is fundamental to the
Aetiology/Causation What caused the disorder and how is this related to the usefulness of the study.
development of illness.
Example: randomized controlled trial - case-control study- In a clinical paper the methodology employed to generate the
cohort study. results is fully explained. In general, all questions about the
Therapy Which treatments do more good than harm compared with related clinical query, the study design, the subjects and the
an alternative treatment?
Example: randomized control trial, systematic review, correlated measures to reduce bias and confounding should be
meta- analysis. adequately and thoroughly explored and answered.
Prognosis What is the likely course of a patient’s illness? Participants/Sample Population:
What is the balance of the risks and benefits of a
treatment? Example: cohort study, longitudinal survey. Researchers identify the target population they are interested in.
Diagnosis How valid and reliable is a diagnostic test? A sample population is therefore taken and results from this
What does the test tell the doctor? sample are then generalized to the target population.
Example: cohort study, case –control study
The sample should be representative of the target population
Cost- effectiveness Which intervention is worth prescribing?
Is a newer treatment X worth prescribing compared with
from which it came. Knowing the baseline characteristics of the
older treatment Y? sample population is important because this allows researchers
Example: economic analysis to see how closely the subjects match their own patients [4].
[Table/Fig-1]: Categories of clinical questions and the related study designs. Sample size calculation (Power calculation): a trial should be large enough
Does it summarize the main findings of the study and relate to have a high chance of detecting a worthwhile effect if it
them to any deficiencies in the study design or problems in the exists. Statisticians can work out before the trial begins how
conduct of the study? (This is called intention to treat analysis). large the sample size should be in order to have a good chance
of detecting a true difference between the intervention and
• Does it address any source of potential bias?
control groups [5].
• Are interpretations consistent with the results?
• Is the sample defined? Human, Animals (type); what population
• How are null findings interpreted?
does it represent?
• Does it mention how do the findings of this study relate to
• Does it mention eligibility criteria with reasons?
previous work in the area?
• Does it mention where and how the sample were recruited,
• Can they be generalized (external validity)?
selected and assessed?
• Does it mention their clinical implications/applicability?
• Does it mention where was the study carried out?
• Who are the results/outcomes/findings applicable to and will
they affect a clinical practice? • Is the sample size justified? Rightly calculated? Is it
adequate to detect statistical and clinical significant results?
• Does the conclusion answer the study question?
• Does it mention a suitable study design /type?
- Is the conclusion convincing?
• Is the study type appropriate to the research question?
- Does the paper indicate ethics approval?
• Is the study adequately controlled? Does it mention type of
- Can you identify potential ethical issues?
randomization process? Does it mention the presence of
- Do the results apply to the population in which you are control group or explain lack of it?
interested?
• Are the samples similar at baseline? Is sample attrition
- Will you use the results of the study? mentioned?
Once you have answered the preliminary and key questions and • All studies report the number of participants/ specimens at
identified the research method used, you can incorporate specific the start of a study, together with details of how many of
questions related to each method into your appraisal process or them completed the study and reasons for incomplete follow
checklist. up if there is any.
1-What is the research question? • Does it mention who was blinded? Are the assessors and
For a study to gain value, it should address a significant problem participants blind to the interventions received?
within the healthcare and provide new or meaningful results. • Is it mentioned how was the data analysed?
Useful structure for assessing the problem addressed in the article is the
• Are any measurements taken likely to be valid?
Problem Intervention Comparison Outcome (PICO) method [3].
Researchers use measuring techniques and instruments that
P = Patient or problem: Patient/Problem/Population:
have been shown to be valid and reliable.
It involves identifying if the research has a focused question. What
Validity refers to the extent to which a test measures what it is
is the chief complaint?
supposed to measure.
E.g.,: Disease status, previous ailments, current medications etc., (the extent to which the value obtained represents the object of
I = Intervention: Appropriately and clearly stated management interest.)
strategy e.g.,: new diagnostic test, treatment, adjunctive therapy - Soundness, effectiveness of the measuring instrument;
etc.,
- What does the test measure?
C= Comparison: A suitable control or alternative
- Does it measure, what it is supposed to be measured?
E.g.,: specific and limited to one alternative choice.
- How well, how accurately does it measure?
O= Outcomes: The desired results or patient related consequences
Reliability: In research, the term reliability means
have to be identified. e.g.,: eliminating symptoms, improving “repeatability” or “consistency”
function, esthetics etc.,
Reliability refers to how consistent a test is on repeated
The clinical question determines which study designs are measurements. It is important especially if assessments are
appropriate. There are five broad categories of clinical questions, as made on different occasions and or by different examiners.
shown in [Table/ Fig-1]. Studies should
www.jcdr.net Azzam Al-Jundi and Salah Sakka, Critical Appraisal of Clinical Research

state the method for appropriate manner produce statistically


assessing the reliability of (random, significant results, i.e., p- data Analysis and Results:
any measurements taken convenience, etc.,)? values quoted are <0.05 [9]. • Assessment of the statistical
and what the intra – significance should be
- Were efforts made to 4-What are the outcome
examiner reliability was evaluated:
ensure a good factors and how are they
[6]. response rate or to measured? - Were the tests appropriate for
the data?
3- Selection issues: minimize the - Are all relevant
occurrence of missing outcomes assessed? - Are confidence intervals or p-
The following questions
data? values given?
should be raised: - Is measurement error
- Were reliability an important source of • How strong is the association
- How were subjects
(reproducibility) and bias? between intervention and
chosen or recruited? If not
random, are validity reported? outcome?
5-What are the study
they representative • In an intervention study, factors and how are they • How precise is the estimate of the
of the population? how were subjects measured? risk?
- Types of Blinding recruited and - Are all the relevant • Does it clearly mention
(Masking) Single, Double, assigned to groups? study factors included the main finding(s) and
Triple? • In a cohort study, how in the study? does the data support
- Is there a control many reached final - Have the factors been them?
group? How was it follow-up? measured using appropriate • Does it mention the clinical
chosen? - Are the subject’s tools? significance of the result?
- How are patients representatives of the • Is adverse event or lack of it
followed up? Who are population to which mentioned?
the dropouts? Why the findings are
• Are all relevant outcomes
and how many are applied? assessed?
there?
- Is there evidence of • Was the sample size
- Are the independent volunteer bias? Was adequate to detect a
(predictor) and there adequate follow- clinically/socially
dependent (outcome) up time? significant result?
variables in the study
- What was the drop- • Are the results
clearly identified, out rate?
defined, and presented in a way to
measured? - Any shortcoming in help in health policy
the methodology can decisions?
- Is there a statement
lead to results that do • Is there measurement error?
about sample size
not reflect the truth. If
issues or statistical • Is measurement error an
clinical practice is
power (especially important source of bias?
changed on the basis
important in negative Confounding Factors:
of these results,
studies)?
patients could be A confounder has a
- If a multicenter study, harmed. triangular relationship with
what quality both the exposure and the
Researchers employ a
assurance measures outcome. However, it is not on the
variety of techniques to
were employed to causal pathway. It makes it
make the methodology
obtain consistency appear as if there is a direct
more robust, such as
across sites? relationship between the
matching, restriction,
- Are there selection randomization, and exposure and the outcome
biases? or it might even mask an
blinding [7].
• In a case-control study, association that would
Bias is the term used to otherwise have been
if exercise habits to be describe an error at any present [9].
compared:
stage of the study that was
- Are the controls 6- What important potential
not due to chance. Bias
appropriate? confounders are considered?
leads to results in which
- Were records of there are a systematic - Are potential confounders
cases and controls examined and controlled for?
deviation from the truth.
reviewed blindly? As bias cannot be - Is confounding an important
- How were possible measured, researchers source of bias?
selection biases need to rely on good 7- What is the statistical method
controlled (Prevalence research design to in the study?
bias, Admission Rate minimize bias [8]. To - Are the statistical
bias, Volunteer bias, minimize any bias within a methods described
Recall bias, Lead study the sample appropriate to compare
Time bias, Detection population should be participants for primary
bias, etc.,)? representative of the and secondary
• Cross Sectional population. It is also outcomes?
Studies: imperative to consider the - Are statistical methods
- Was the sample sample size in the study specified insufficient
selected in an and identify if the study is detail (If I had access
adequately powered to
Azzam Al-Jundi and Salah Sakka, Critical Appraisal of Clinical Research www.jcdr.net

to the raw data, significant and the extrapolate beyond the materials as well as non-
could I reproduce null hypothesis is data? English language studies?
the analysis)? accepted. - Are shortcomings of the
- Were the tests appropriate Confidence interval: study addressed and
for the data? Multiple repetition of the constructive suggestions
- Are confidence intervals or same trial would not yield given for future
p-values given? the exact same results research?
- Are results every time. However, on - Is the conclusion
presented as average the results would be convincing?
absolute risk within a certain range. A - Bibliography/References
reduction as well as 95% confidence interval :
relative risk means that there is a
95% chance that the true Do the citations follow one of
reduction?
size of effect will lie within the Council of Biological
Interpretation of p-value: Editors’ (CBE) standard
this range.
The p-value refers to the formats?
8- Statistical results:
probability that any 10- Are ethical issues
particular outcome would - Do statistical tests answer
considered?
have arisen by chance. the research question?
If a study involves human
A p-value of less than 1 Are statistical tests
subjects, human tissues, or
in 20 (p<0.05) is performed and
animals, was approval from
statistically significant. comparisons made (data
appropriate institutional or
• When p-value is less searching)?
governmental entities
than significance level, Correct statistical obtained? [10,11].
which is usually 0.05, analysis of results is
we often reject the crucial to the reliability of - Does the paper indicate
ethics approval?
null hypothesis and the conclusions drawn
the result is from the research paper. - Can you identify
considered to be Depending on the study potential ethical issues?
statistically design and sample Critical appraisal of RCTs:
significant. selection method Factors to look for:
Conversely, when p- employed, observational • Allocation (randomization,
value is greater than or inferential statistical stratification, confounders).
0.05, we conclude analysis may be carried • Blinding.
that the result is not out on the results of the
• Follow up of participants
statistically study.
(intention to treat).
It is important to identify if - If the results are • Data collection (bias).
this is appropriate for the statistically significant, • Sample size (power
study [9]. do they also have clinical calculation).
- Was the sample size significance? • Presentation of results
adequate to detect a - If the results are not (clear, precise).
clinically/socially statistically significant, • Applicability to local
significant result? was the sample size population.
- Are the results sufficiently large to [Table/Fig-2] summarizes the
presented in a way to detect a meaningful guidelines for Consolidated
help in health policy difference or effect?
Standards of Reporting Trials
decisions? 9- What conclusions did the CONSORT [12].
Clinical significance: authors reach about the
Critical appraisal of
Statistical significance as study question?
systematic reviews: provide
shown by p-value is not Conclusions should ensure an overview of all primary
the same as clinical that recommendations stated studies on a topic and try to
significance. Statistical are suitable for the results obtain an overall picture of
significance judges attained within the capacity of the results.
whether treatment effects the study. The authors should
are explicable as chance also concentrate on the In a systematic review, all the
findings, whereas clinical limitations in the study and primary studies identified are
significance assesses their effects on the outcomes critically appraised and only
whether treatment effects and the proposed the best ones are selected. A
are worthwhile in real life. suggestions for future studies meta-analysis (i.e., a
Small improvements that [10]. statistical analysis) of the
are statistically significant results from selected studies
- Are the questions posed
might not result in any in the study adequately may be included. Factors to
meaningful improvement addressed? look for:
clinically. The following - Are the conclusions • Literature search (did it
questions should always justified by the data? include published and
be on mind: unpublished
- Do the authors
www.jcdr.net Azzam Al-Jundi and Salah Sakka, Critical Appraisal of Clinical Research

personal contact with [Table/Fig-3]: Summary of PRISMA guidelines.


experts sought?).
• Quality-control of CONCLUsION
studies included Critical appraisal is a
(type of study; fundamental skill in
scoring system used modern practice for
to rate studies; assessing the value of
analysis performed clinical researches and
by at least two providing an indication
experts).
of their relevance to the
• Homogeneity of studies. profession. It is a skills-
• Presentation of results (clear, set developed
precise). throughout a
• Applicability to local professional career that
population. facilitates this and,
[Table/Fig-3] summarizes the through
guidelines for Preferred Reporting
Items for Systematic reviews and
Meta-Analyses PRISMA [13].

Identification as a RCT in the title- Structured summary


Title and abstract
(trial design, methods, results, and conclusions)
Introduction - Scientific background
- Objectives
Methods -Description of trial design and important changes to
methods
-Eligibility criteria for participants
-The interventions for each group
-Completely defined and assessed primary and secondary
outcome measures
-How sample size was determined
-Method used to generate the random allocation sequence
-Mechanism used to implement the random allocation
sequence
-Blinding details
-Statistical methods used
Results -Numbers of participants, losses and exclusions after
randomization
-Results for each
its precision (such as 95% confidence
-Results of any other subgroup analyses performed
Discussion -Trial limitations
-Generalisability
Other information - Registration number
[Table/Fig-2]: Summary of the CONSORT guidelines.

Identification of the report as a systematic review,


Title

Abstract Structured Summary: background; objectives; eligibility criteria;


results; limitations; conclusions; systematic
number.

Introduction - Description of the rationale for the review


- Provision of a defined statement of questions being
concentrated on with regard to participants, interventions,
comparisons, outcomes, and study design (PICOS).

Methods - Specification of study eligibility


- Description of all information
- Presentation of full electronic search strategy
- State the process for selecting
- Description of the method of data extraction from
and methods used for assessing risk of bias of individual
studies in addition to methods of handling data
combining results of
Results Provision of full details of:
- Study selection.
- Study characteristics
period)
- Risk of bias within
- Results of each
confidence intervals and measures of
- Methods of additional
subgroup analyses,
Discussion -Summary of the main findings including the strength of
evidence for each main outcome.
- Discussion of limitations at study and outcome level.
- Provision of a general concluded interpretation of the
results in the context of other evidence.
Funding Source and role of funders.
integration with clinical experience and patient preference, [6] Sakka S, Al-ani Z, Kasioumis T, Worthington H, Coulthard P. Inter-examiner and intra-
examiner reliability of the measurement of marginal bone loss around oral
permits the practice of evidence based medicine and dentistry. implants. Implant Dent. 2005;14(4):386-88.
By following a systematic approach, such evidence can be [7] Rosenberg W, Donald A. Evidence based medicine: an approach to clinical
considered and applied to clinical practice. problem-solving. BMJ. 1995;310(6987):1122-26.
[8] Stewart LA, Parmar, MK. Bias in the analysis and reporting of randomized
controlled trials. Int J Technol Assess Health Care. 1996;12(2):264-75.
REFERENCEs [9] Egger M, Smith GD. Bias in location and selection of studies. BMJ.
[1] Burls, A. What is critical appraisal? 1998;316(7124):61-66.
2016: London, Hayward Medical [ Haynes RB. Of studies, syntheses,
Communications. Available from: 1 synopses, summaries, and
[2] http://www.whatisseries.co.uk/what- 0 systems: the "5S" evolution of
is-critical- appraisal/ . ] information services for
[3] MacInnes A, Lamont T. Critical evidence-based healthcare
Appraisal of a Research Paper. Scott decisions. Evid Based Med.
[4] Uni Med J. 2014;3 (1):10-17. [ 2006;11(6):162-64
Richards D, Lawrence A. Evidence- 1 Al-Jundi A, Sakka S. Protocol
1 Writing in Clinical Research. J
[5] based dentistry. Br Dent J. ] Clin
1995;179(7):270- Diagn Res.
73. 2016;10(11):ZE10-ZE13
Sackett DL, Rosenberg WM, Gray JA, [ Moher D, Hopewell S, Schulz KF,
Haynes RB, Richardson WS. Evidence 1 Montori V, Gøtzsche PC,
2 Devereaux PJ, et al. CONSORT
based medicine: what it is and what it
] 2010 Explanation and
isn’t. BMJ. 1996;312(7023):71-72.
Greenhalgh, T. How to read a paper: Elaboration: updated
The basics of evidence based medicine. guidelines for reporting
5th ed, New York, United States; [ parallel group randomised trials.
1 BMJ 2010;340:c869.
John Wiley & Sons: 2014.
3 Moher D, Liberati A, Tetzlaff J,
] Altman DG, The PRISMA
Group. Preferred Reporting
Items for Systematic Reviews
and Meta-Analyses: The
PRISMA Statement. PLoS Med.
2009;6(7):e1000097.

PARTICulARS OF COnTRIBuTORS:
1. Professor, Department of Orthodontics, King Saud bin Abdul Aziz
University for health sciences-College of dentistry. Riyadh, Kingdom of
Saudi Arabia.
2. Associate Professor, Department of Oral and Maxillofacial Surgery, Al
Farabi Dental College. Riyadh, KSA.

nAmE, AddRESS, E-
mAIl Id OF ThE
CORRESPOndInG D
AuThOR: a
Dr. Salah Sakka, t
Associate Professor, Al- e
Farabi Dental College,
Riyadh-11691, Kingdom of
Saudi Arabia. o
E-mail: f
salah.sakka@hotmail.
com
S
u
FInAnCIAl OR
b
OThER COmPETInG
InTERESTS: None. m
i
s
s
i
o
n
:

d
e
c

1
6
,

2
0
1
6

D
a
t
e

o
f
www.jcdr.net Azzam Al-Jundi and Salah Sakka, Critical Appraisal of Clinical Research
Peer Review: 01,
Feb 14, 2017 2017
Date of
Acceptance:
Apr 04, 2017
Date of Publishing: may

Journal of Clinical and Diagnostic Research. 2017 May, Vol-11(5): JE01-JE05 5 5


View publication stats

You might also like